Suppr超能文献

简单有机阳离子被多药耐药细胞识别的结构要求。

Structural requirements of simple organic cations for recognition by multidrug-resistant cells.

作者信息

Dellinger M, Pressman B C, Calderon-Higginson C, Savaraj N, Tapiero H, Kolonias D, Lampidis T J

机构信息

Museum d'Histoire Naturelle, Departement de Biophysiques, Paris, France.

出版信息

Cancer Res. 1992 Nov 15;52(22):6385-9.

PMID:1358433
Abstract

We previously noted that a wide variety of drugs which are recognized by multidrug-resistant cells (MDR+) are positively charged. However, it remains unclear why and how such a large number of structurally different compounds can be distinguished by MDR+ cells. The majority of the diverse compounds subject to MDR are complex and thereby complicate definitive structure/function characterization of the P-glycoprotein-mediated MDR mechanism. Using a series of simple aromatic (alkypyridiniums) and nonaromatic (alkylguanidiniums) organic cations differing in their lipophilicity by stepwise additions of single alkyl carbons, we demonstrate by growth inhibition studies that a single aromatic moiety and a critical degree of lipophilicity (log P > -1) are required for recognition of these simple organic cations by MDR+ cells. Thus, MDR+ cells are not cross-resistant to the nonaromatic guanidiniums but do show cross-resistance to those aromatic pyridiniums with chain lengths > four. Resistance ratios, as determined by comparison of 50% inhibitory doses in MDR- versus MDR+ cells, increase as a function of increasing chain lengths of these latter simple aromatic compounds. Resistance to pyridinium analogues in MDR+ cells is reversible by co-treatment with nontoxic doses of verapamil. Preliminary uptake data with radioactive analogues further implicate the MDR mechanism of lowered drug accumulation in accounting for resistance to the pyridinium homologues. Utilization of these simple organic cations provides a rational basis for better defining the physical chemical properties of more complex compounds processed by the MDR mechanism and suggests a strategy for designing chemotherapeutic agents with reduced susceptibility to MDR.

摘要

我们之前注意到,多种能被多药耐药细胞(MDR+)识别的药物都带正电荷。然而,目前仍不清楚为何以及MDR+细胞如何能区分如此大量结构不同的化合物。大多数受多药耐药影响的不同化合物都很复杂,这使得对P-糖蛋白介导的多药耐药机制进行明确的结构/功能表征变得复杂。我们使用了一系列简单的芳香族(烷基吡啶鎓)和非芳香族(烷基胍鎓)有机阳离子,它们通过逐步添加单个烷基碳在亲脂性上有所不同,通过生长抑制研究表明,MDR+细胞识别这些简单有机阳离子需要一个单一的芳香部分和一定程度的亲脂性(log P > -1)。因此,MDR+细胞对非芳香族胍鎓没有交叉耐药性,但对链长大于四个碳的芳香族吡啶鎓确实表现出交叉耐药性。通过比较MDR-细胞与MDR+细胞中的50%抑制剂量所确定的耐药比,随着这些后一种简单芳香化合物链长的增加而增加。MDR+细胞对吡啶鎓类似物的耐药性可通过与无毒剂量的维拉帕米共同处理而逆转。用放射性类似物进行的初步摄取数据进一步表明,药物积累降低的多药耐药机制是导致对吡啶鎓同系物耐药的原因。利用这些简单的有机阳离子为更好地定义通过多药耐药机制处理的更复杂化合物的物理化学性质提供了合理依据,并提出了一种设计对多药耐药敏感性降低的化疗药物的策略。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验